Eric M. Mucker

2.6k total citations
40 papers, 1.8k citations indexed

About

Eric M. Mucker is a scholar working on Virology, Epidemiology and Molecular Biology. According to data from OpenAlex, Eric M. Mucker has authored 40 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Virology, 21 papers in Epidemiology and 20 papers in Molecular Biology. Recurrent topics in Eric M. Mucker's work include Poxvirus research and outbreaks (25 papers), Herpesvirus Infections and Treatments (19 papers) and Bacillus and Francisella bacterial research (18 papers). Eric M. Mucker is often cited by papers focused on Poxvirus research and outbreaks (25 papers), Herpesvirus Infections and Treatments (19 papers) and Bacillus and Francisella bacterial research (18 papers). Eric M. Mucker collaborates with scholars based in United States, United Kingdom and China. Eric M. Mucker's co-authors include John W. Huggins, Joshua D. Shamblin, Jay W. Hooper, David Miller, David A. Kulesh, Peter B. Jahrling, Arthur J. Goff, Lisa E. Hensley, Joseph W. Golden and Jennifer Chapman and has published in prestigious journals such as Nature, PLoS ONE and Journal of Virology.

In The Last Decade

Eric M. Mucker

40 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric M. Mucker United States 22 1.2k 999 969 459 271 40 1.8k
Lisa Strelow United States 17 657 0.5× 580 0.6× 960 1.0× 249 0.5× 612 2.3× 27 1.8k
Scott J. Goebel United States 25 1.0k 0.9× 666 0.7× 1.0k 1.1× 620 1.4× 287 1.1× 30 2.4k
Antony S. Dimitrov United States 20 823 0.7× 603 0.6× 973 1.0× 853 1.9× 367 1.4× 36 2.0k
Songtao Yang China 26 355 0.3× 460 0.5× 582 0.6× 863 1.9× 214 0.8× 92 1.8k
D. Noah Sather United States 27 1.3k 1.1× 768 0.8× 365 0.4× 557 1.2× 1.1k 4.1× 70 2.4k
Joshua D. Shamblin United States 20 465 0.4× 420 0.4× 507 0.5× 881 1.9× 180 0.7× 36 1.5k
Susan Payne United States 24 519 0.4× 263 0.3× 913 0.9× 603 1.3× 158 0.6× 55 1.7k
Scott Parker United States 24 1.3k 1.1× 931 0.9× 1.0k 1.0× 287 0.6× 370 1.4× 42 1.7k
E. Ashley Thompson United States 8 536 0.4× 386 0.4× 443 0.5× 417 0.9× 211 0.8× 9 1.0k
Rui Pedro Galão United Kingdom 17 330 0.3× 383 0.4× 249 0.3× 362 0.8× 395 1.5× 22 1.1k

Countries citing papers authored by Eric M. Mucker

Since Specialization
Citations

This map shows the geographic impact of Eric M. Mucker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric M. Mucker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric M. Mucker more than expected).

Fields of papers citing papers by Eric M. Mucker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric M. Mucker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric M. Mucker. The network helps show where Eric M. Mucker may publish in the future.

Co-authorship network of co-authors of Eric M. Mucker

This figure shows the co-authorship network connecting the top 25 collaborators of Eric M. Mucker. A scholar is included among the top collaborators of Eric M. Mucker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric M. Mucker. Eric M. Mucker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mudhasani, Rajini, Joseph W. Golden, Gregory C. Adam, et al.. (2024). Orally available nucleoside analog UMM-766 provides protection in a murine model of orthopox disease. Microbiology Spectrum. 12(4). e0358623–e0358623. 2 indexed citations
2.
Cotter, Catherine A., Jeffrey L. Americo, Patricia L. Earl, et al.. (2024). Mpox mRNA-1769 vaccine inhibits orthopoxvirus replication at intranasal, intrarectal, and cutaneous sites of inoculation. npj Vaccines. 9(1). 256–256. 5 indexed citations
3.
Davis, Ian, Christopher P. Stefan, Janice A. Williams, et al.. (2023). Development of a specific MPXV antigen detection immunodiagnostic assay. Frontiers in Microbiology. 14. 1243523–1243523. 16 indexed citations
4.
Mucker, Eric M., Arthur J. Goff, Todd M. Bell, et al.. (2022). Evaluation of Virulence in Cynomolgus Macaques Using a Virus Preparation Enriched for the Extracellular Form of Monkeypox Virus. Viruses. 14(9). 1993–1993. 8 indexed citations
5.
Liu, Jun, Eric M. Mucker, Jennifer Chapman, et al.. (2022). Retrospective detection of monkeypox virus in the testes of nonhuman primate survivors. Nature Microbiology. 7(12). 1980–1986. 20 indexed citations
6.
Mucker, Eric M., et al.. (2022). Effect of Monkeypox Virus Preparation on the Lethality of the Intravenous Cynomolgus Macaque Model. Viruses. 14(8). 1741–1741. 10 indexed citations
7.
Zhang, Qi, Lin Cheng, Jiwan Ge, et al.. (2022). Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2. Frontiers in Immunology. 13. 980435–980435. 12 indexed citations
8.
Golden, Joseph W., Xiankun Zeng, Aura R. Garrison, et al.. (2021). Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease. Journal of General Virology. 102(5). 5 indexed citations
9.
Golden, Joseph W., Xiankun Zeng, Aura R. Garrison, et al.. (2020). Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease. JCI Insight. 5(19). 132 indexed citations
10.
11.
Honko, Anna N., Louis A. Altamura, Sandra L. Bixler, et al.. (2018). Virus-encoded miRNAs in Ebola virus disease. Scientific Reports. 8(1). 6480–6480. 27 indexed citations
12.
Mucker, Eric M., et al.. (2017). Validation of a pan-orthopox real-time PCR assay for the detection and quantification of viral genomes from nonhuman primate blood. Virology Journal. 14(1). 210–210. 9 indexed citations
13.
Warren, Travis K., John C. Trefry, Taylor Chance, et al.. (2014). Euthanasia Assessment in Ebola Virus Infected Nonhuman Primates. Viruses. 6(11). 4666–4682. 17 indexed citations
14.
Mucker, Eric M., Arthur J. Goff, Joshua D. Shamblin, et al.. (2013). Efficacy of Tecovirimat (ST-246) in Nonhuman Primates Infected with Variola Virus (Smallpox). Antimicrobial Agents and Chemotherapy. 57(12). 6246–6253. 75 indexed citations
15.
Malhotra, S., Judy Yen, Anna N. Honko, et al.. (2013). Transcriptional Profiling of the Circulating Immune Response to Lassa Virus in an Aerosol Model of Exposure. PLoS neglected tropical diseases. 7(4). e2171–e2171. 24 indexed citations
16.
Jordan, Robert, Arthur J. Goff, Michael L. Corrado, et al.. (2009). ST-246 Antiviral Efficacy in a Nonhuman Primate Monkeypox Model: Determination of the Minimal Effective Dose and Human Dose Justification. Antimicrobial Agents and Chemotherapy. 53(5). 1817–1822. 108 indexed citations
17.
Loveless, Bonnie M., et al.. (2009). Differentiation of Variola major and Variola minor variants by MGB-Eclipse probe melt curves and genotyping analysis. Molecular and Cellular Probes. 23(3-4). 166–170. 6 indexed citations
18.
Birkenheuer, Adam J., et al.. (2008). Cytauxzoon felis infections are present in bobcats (Lynx rufus) in a region where cytauxzoonosis is not recognized in domestic cats. Veterinary Parasitology. 153(1-2). 126–130. 40 indexed citations
19.
Goff, Arthur J., Nancy Twenhafel, Aura R. Garrison, et al.. (2007). In vivo imaging of cidofovir treatment of cowpox virus infection. Virus Research. 128(1-2). 88–98. 18 indexed citations
20.
Edghill‐Smith, Yvette, Mike Bray, Chris A. Whitehouse, et al.. (2005). Smallpox Vaccine Does Not Protect Macaques with AIDS from a Lethal Monkeypox Virus Challenge. The Journal of Infectious Diseases. 191(3). 372–381. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisa Strelow Breakdown of academic impact, for papers by Scott J. Goebel Breakdown of academic impact, for papers by Antony S. Dimitrov Breakdown of academic impact, for papers by Songtao Yang Breakdown of academic impact, for papers by D. Noah Sather Breakdown of academic impact, for papers by Joshua D. Shamblin Breakdown of academic impact, for papers by Susan Payne Breakdown of academic impact, for papers by Scott Parker Breakdown of academic impact, for papers by E. Ashley Thompson Breakdown of academic impact, for papers by Rui Pedro Galão
Rankless by CCL
2026